JNJ-7925476
JNJ-7925476
JNJ-7925476 (/ˈdʒeɪˈɛnˈdʒeɪˈsevənˈnaɪntuːˈfaɪvˈfɔːˈsevənˈsɪks/) is a pharmaceutical compound currently under investigation for its potential therapeutic effects.
Etymology
The name "JNJ-7925476" is derived from the initials of the pharmaceutical company Johnson & Johnson (JNJ), followed by a unique numerical identifier (7925476) assigned to the compound during the drug discovery and development process.
Pharmacology
JNJ-7925476 is a novel compound that is being studied for its potential use in the treatment of various medical conditions. The exact mechanism of action and pharmacological properties of JNJ-7925476 are currently under investigation.
Related Terms
- Pharmaceutical compound: A substance that is designed and developed for use as a medicinal drug.
- Johnson & Johnson: An American multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.
- Drug discovery: The process through which potential new medicines are identified.
- Drug development: The process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.
External links
- Medical encyclopedia article on JNJ-7925476
- Wikipedia's article - JNJ-7925476
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski